AIChE Journal Highlight: Advancing Quality by Design in Pharmaceuticals

May
,
2018

Although pharmaceutical manufacturing has a rich history of delivering lifesaving drugs and therapies to patients, quality control concerns within manufacturing facilities as well as patient safety incidents prompted the creation of regulatory agencies. Thus, the history of pharmaceutical manufacturing is intertwined with the evolution of worldwide regulations intended to ensure the safety of medicines, writes Paul C. Collins in the May AIChE Journal Perspective article, “Chemical Engineering and the Culmination of Quality by Design in Pharmaceuticals.”

“Many of the regulatory expectations were enacted during a time when the ability to provide process monitoring and true process control in pharmaceutical manufacturing facilities was not technically possible,” says Collins. “Therefore, the quality controls exacted upon pharmaceutical manufacturing processes, referred to as Good Manufacturing Practices (GMPs), were largely procedural in nature.” The focus on procedural compliance meant that pharmaceutical manufacturing technologies lagged behind those of other chemical processing industries.

The current regulations were formed to help existing manufacturing...

Would you like to access the complete CEP Article?

No problem. You just have to complete the following steps.

You have completed 0 of 2 steps.

  1. Log in

    You must be logged in to view this content. Log in now.

  2. AIChE Membership

    You must be an AIChE member to view this article. Join now.

Copyright Permissions: 

Would you like to reuse content from CEP Magazine? It’s easy to request permission to reuse content. Simply click here to connect instantly to licensing services, where you can choose from a list of options regarding how you would like to reuse the desired content and complete the transaction.